161 related articles for article (PubMed ID: 12970455)
1. Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein.
Earl PL; Americo JL; Moss B
J Virol; 2003 Oct; 77(19):10684-8. PubMed ID: 12970455
[TBL] [Abstract][Full Text] [Related]
2. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.
Johnson MC; Damon IK; Karem KL
J Virol Methods; 2008 Jun; 150(1-2):14-20. PubMed ID: 18387679
[TBL] [Abstract][Full Text] [Related]
3. Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.
Cosma A; Bühler S; Nagaraj R; Staib C; Hammarin AL; Wahren B; Goebel FD; Erfle V; Sutter G
Clin Diagn Lab Immunol; 2004 Mar; 11(2):406-10. PubMed ID: 15013995
[TBL] [Abstract][Full Text] [Related]
4. A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
Liu Q; Huang W; Nie J; Zhu R; Gao D; Song A; Meng S; Xu X; Wang Y
PLoS One; 2012; 7(3):e33392. PubMed ID: 22438922
[TBL] [Abstract][Full Text] [Related]
5. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.
Di Lullo G; Soprana E; Panigada M; Palini A; Agresti A; Comunian C; Milani A; Capua I; Erfle V; Siccardi AG
J Virol Methods; 2010 Feb; 163(2):195-204. PubMed ID: 19778556
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
Manischewitz J; King LR; Bleckwenn NA; Shiloach J; Taffs R; Merchlinsky M; Eller N; Mikolajczyk MG; Clanton DJ; Monath T; Weltzin RA; Scott DE; Golding H
J Infect Dis; 2003 Aug; 188(3):440-8. PubMed ID: 12870127
[TBL] [Abstract][Full Text] [Related]
8. Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation.
Leparc-Goffart I; Poirier B; Garin D; Tissier MH; Fuchs F; Crance JM
J Clin Virol; 2005 Jan; 32(1):47-52. PubMed ID: 15572006
[TBL] [Abstract][Full Text] [Related]
9. Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high-throughput assay.
Kennedy R; Pankratz VS; Swanson E; Watson D; Golding H; Poland GA
Clin Vaccine Immunol; 2009 Aug; 16(8):1105-12. PubMed ID: 19535540
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of human immunological responses to vaccinia virus.
Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW
Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020
[TBL] [Abstract][Full Text] [Related]
11. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine.
Weltzin R; Liu J; Pugachev KV; Myers GA; Coughlin B; Blum PS; Nichols R; Johnson C; Cruz J; Kennedy JS; Ennis FA; Monath TP
Nat Med; 2003 Sep; 9(9):1125-30. PubMed ID: 12925845
[TBL] [Abstract][Full Text] [Related]
12. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.
Borges MB; Kato SE; Damaso CR; Moussatché N; da Silva Freire M; Lambert Passos SR; do Nascimento JP
Biologicals; 2008 Mar; 36(2):105-10. PubMed ID: 17892944
[TBL] [Abstract][Full Text] [Related]
13. Clinical development of Modified Vaccinia virus Ankara vaccines.
Gilbert SC
Vaccine; 2013 Sep; 31(39):4241-6. PubMed ID: 23523410
[TBL] [Abstract][Full Text] [Related]
14. Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry.
Domínguez J; Lorenzo MM; Blasco R
J Immunol Methods; 1998 Nov; 220(1-2):115-21. PubMed ID: 9839932
[TBL] [Abstract][Full Text] [Related]
15. [Development of a numerically additive combined vaccine against tetanus and smallpox].
Mayr A; Baljer G; Wagner C; Sailer J
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
[TBL] [Abstract][Full Text] [Related]
16. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
Xiao Y; Aldaz-Carroll L; Ortiz AM; Whitbeck JC; Alexander E; Lou H; Davis HL; Braciale TJ; Eisenberg RJ; Cohen GH; Isaacs SN
Vaccine; 2007 Jan; 25(7):1214-24. PubMed ID: 17098336
[TBL] [Abstract][Full Text] [Related]
17. Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine.
Esparza J; Schrick L; Damaso CR; Nitsche A
Vaccine; 2017 Dec; 35(52):7222-7230. PubMed ID: 29137821
[TBL] [Abstract][Full Text] [Related]
18. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.
Kaever T; Matho MH; Meng X; Crickard L; Schlossman A; Xiang Y; Crotty S; Peters B; Zajonc DM
J Virol; 2016 May; 90(9):4334-4345. PubMed ID: 26889021
[TBL] [Abstract][Full Text] [Related]
19. Detection of vaccinia virus DNA, but not infectious virus, in the blood of smallpox vaccine recipients.
Cohen JI; Hohman P; Preuss JC; Li L; Fischer SH; Fedorko DP
Vaccine; 2007 Jun; 25(23):4571-4. PubMed ID: 17493714
[TBL] [Abstract][Full Text] [Related]
20. IMMUNOGENICITY OF ULTRAVIOLET-IRRADIATED, NON-INFECTIOUS, VACCINIA-VIRUS VACCINE IN INFANTS AND YOUNG CHILDREN.
KAPLAN C; BENSON PF; BUTLER NR
Lancet; 1965 Mar; 1(7385):573-4. PubMed ID: 14250081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
